← Leaderboards
Rajendra Kumar-Singh
University Of Utah
$5,865,814
Attributed
$5,865,814
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $986K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,865,814 · 3
By mechanism
R01$5,865,814 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Josh Leitch Bonkowsky$6,570,963
- William I Higuchi$5,488,090
- Austin Edward Schlirf$17,102
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyRetinitis PigmentosaIn VivoVectorPhotoreceptorsGene TransferRetinal DegenerationAdenovirusesStructure Of Retinal Pigment EpitheliumGeneticRetinaBlindnessPhotoreceptor DegenerationCellsVirusProteinsRetinalImmune ResponseAnimal ModelInsertional MutagenesisAmericanGene Transfer VectorPhase I Clinical TrialsGenes
Grant awards (18)
Non-Viral Gene Therapy for Retinal Degeneration$404,250
R01 · FY2014 · EY · contact PI
Non-Viral Gene Therapy for Retinal Degeneration$391,875
R01 · FY2013 · EY · contact PI
Non-Viral Gene Therapy for Retinal Degeneration$412,500
R01 · FY2012 · EY · contact PI
Gene Therapy for Retinitis Pigmentosa$392,040
R01 · FY2012 · EY · contact PI
Non-Viral Gene Therapy for Retinal Degeneration$181,500
R01 · FY2012 · EY · contact PI
Non-Viral Gene Therapy for Retinal Degeneration$412,500
R01 · FY2011 · EY · contact PI
Gene Therapy for Retinitis Pigmentosa$392,040
R01 · FY2011 · EY · contact PI
Gene Therapy for Retinitis Pigmentosa$408,375
R01 · FY2010 · EY · contact PI
Gene Therapy for Retinitis Pigmentosa$412,188
R01 · FY2009 · EY · contact PI
VP22 AND TAT mediated gene therapy for the CNS$159,251
R01 · FY2009 · EY · contact PI
VP22 AND TAT mediated gene therapy for the CNS$317,527
R01 · FY2007 · EY · contact PI
VP22 AND TAT mediated gene therapy for the CNS$319,316
R01 · FY2006 · EY · contact PI
Gene Therapy for Retinitis Pigmentosa$279,402
R01 · FY2006 · EY · contact PI
VP22 AND TAT mediated gene therapy for the CNS$299,000
R01 · FY2005 · EY
Gene Therapy for Retinitis Pigmentosa$261,625
R01 · FY2005 · EY
VP22 AND TAT mediated gene therapy for the CNS$299,000
R01 · FY2004 · EY
Gene Therapy for Retinitis Pigmentosa$261,625
R01 · FY2004 · EY
Gene Therapy for Retinitis Pigmentosa$261,800
R01 · FY2003 · EY